Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Targeted Levothyroxine Dosing in Congenital Hypothyroidism
NCT02374593Completed
- Start
- Mar 2014
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of levothyroxine sodium in congenital hypothyroidism (CH) (2 arms). Primary endpoint: Frequency of Dose Adjustments at 6 months. Started Mar 2014; status: completed.
02
Drugs
levothyroxine sodium
03
Conditions
congenital hypothyroidism (CH)
Beyond the preview
Go deeper on NCT02374593.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02374593.